EUSA names new CEO
This article was originally published in Scrip
Executive Summary
EUSA Pharma, a recently established specialty pharmaceutical company, has named Lee Morley CEO and Dr Göran Ando non-executive director. Mr Morley joins EUSA from Jazz Pharmaceuticals, where he was vice-president and head of commercial for Europe and international markets. At Jazz, Mr Morley had responsibility for the original EUSA Pharma business following its acquisition in 2012, until the recent launch of EUSA as a newly established independent company. He has also previously held a number of management positions in sales and marketing at Merck Sharp and Dohme.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.